The materials assessed in this report have close structural relationships and similar biochemical and toxicity profiles. They generally participate in the same pathways of metabolic detoxication. The terpene alcohols are dermally absorbed, and a significant amount can be retained briefly within the epidermis, dermis, and subcutaneous tissue. Some have a penetration enhancing effect in vitro. Few data are available from which to characterize the oral bioavailability of the terpene alcohols. For the assessment of potential oral exposures, bioavailability is therefore assumed to be 100%. Based on the data reviewed, the terpene alcohols are expected to undergo extensive conjugation and metabolism by well-characterized pathways, primarily in the liver, to form more polar compounds that are excreted mainly in the urine and to a lesser extent in the feces. They form generally innocuous end products: primary alcohols are metabolized to corresponding aldehydes and acids, and ultimately to CO2, and secondary alcohols are conjugated with glucuronide and excreted. Unsaturated alcohols may undergo further oxidation at the point of unsaturation or be oxidized to the corresponding acid prior to conjugation and excretion in the urine. A few materials, however, may generate α,β-unsaturated metabolites or hydroperoxides. The acute dermal toxicity of the terpene alcohols is very low, with LD50 values in rabbits reported to be greater than 2000 mg/kg body weight. The acute oral toxicity is likewise low with LD50 values generally greater than 1000 mg/kg body weight. Dermal repeated dose toxicity studies have been conducted only with linalool and α-bisabolol and indicated, apart from local effects, a low magnitude of systemic toxicity with NOAELs of 250 and 200 mg/kg body weight/day, respectively. Slight effects on body weight and food consumption were observed at a dose level of 1000 mg/kg body weight/day. The liver and kidneys were the only target organs affected in oral repeated dose toxicity studies. The magnitude of systemic toxicity is considered to be low with NOAELs generally greater than 50 mg/kg body weight/day. Hence, it can be assumed that efficient detoxication mechanisms are in place to prevent significant toxicity. Terpene alcohols have been extensively tested in genotoxicity studies in vitro. Ames and other bacterial mutation data demonstrate no mutagenic activity of this group of compounds. A few positive results have been obtained in chromosome aberration studies in vitro, but these materials showed no evidence of genotoxicity in vivo. The relevance of the positive findings is, therefore, limited. Reproductive and developmental toxicity data are limited but give no indication of a relevant adverse effect on reproductive function or the developing organism. NOAELs for maternal and developmental toxicity are far in excess of current human exposure levels and raise no safety concern. At concentrations likely to be encountered by consumers, these chemicals are considered non-irritating to human skin. Their potential for eye irritation under the present maximum use concentrations is considered minimal. Cases of sensitization, mostly in dermatitis patients, have been reported for many of the assessed terpene alcohols. Due to their sensitizing effects, 6,7-dihydrogeraniol, hydroabietyl alcohol and isopropyl-2-decahydronaphthalenol have been prohibited for use in fragrance materials. Restrictions exist for farnesol, geraniol, citronellol and rhodinol (3,7-dimethyl-7-octen-1-ol). Sclareol and linalool must comply with specific purity criteria if used as fragrance materials. No test results were available for some materials. 2(10)-Pinen-3-ol and 2,6-dimethyloct-3,5-dien-2-ol do not have structural alerts for topical effects (Ford et al., 2000). Based on structural elements that indicate a potential for sensitization, 3,7-dimethyl-4,6-octadien-3-ol, should be regarded as a potential sensitizer until tested. Based on the UV spectra and review of phototoxic/photoallergy data, terpene alcohols would not be expected to elicit phototoxicity or photoallergy under the current conditions of use as a fragrance ingredient.